DEXWireNews

$ATOS Speculation in Atossa Genetics continues pre 25th April.

NASDAQ:ATOS   Atossa Therapeutics, Inc.
The rumor mill continues to spin in ATOS prior to a presentation scheduled for April the 25th, the spike in volume hopefully preempts a positive move. Keep it on the watchlist.

⭐⭐⭐ Sign Up for Free ⭐⭐⭐

1) Download our App on Google Play! dexwirenews.com/APP

2) Text Message Notifications: dexwirenews.com/SMS

3) Telegram: t.me/DEXWireNews

4) Follow Us on our Social Networks
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.